2-(4-methoxyphenyl)-1-(2-methylpiperazin-1-yl)ethan-1-one, 95.0%, 2g

C-(5-p-Tolyl-[1,3,4]oxadiazol-2-yl)-methylamine; hydrochloride, 95.0%, 1g

6-Bromo-3-hydroxyisoquinoline, 98.0%, 1g

2-Iodoacetamide [for Biochemical Research]>98.0%(N)5g

4,4-DIFLUORO-3,3-DIMETHYLPIPERIDINE HCL, 95.0%, 1g

4-nitroaniline, min. 98.5%, for synthesis, 100 g, plastic packaging.

Ethyl 2-(2-Benzothiazolyl)acetate>95.0%(GC)5g

3-Bromo-2,5-dimethylthiophene, 95%, 250mg

(4-Methoxy-phenyl)-morpholin-4-yl-acetic acid; hydrochloride, 95.0%, 1g

(S)-2-(3-((1R,2R)-2-Aminocyclohexyl)thioureido)-N-benzyl-N,3,3-trimethylbutanamide, 98%, 100mg

2-Amino-5-trifluoromethoxy-benzoic acid, 98.0%, 5g

3-(4-Chloro-2-methylphenoxy)azetidine, 95+%, 250mg

1-Cyclohexylpropan-2-amine hydrochloride, 95.0%, 50mg